MoneyWorks4Me

Wanbury - Quaterly Results

07 Jul 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 1329.75 millions against Rs. 1343.94 millions recorded during the year-ago period.Net profit was down at Rs. 10.15  millions against Rs. 825.45 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -98.77%.A decline of 121.02 millions was observed in the OP in the quarter ended March 2023 from 134.54 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202203 202103 % Var
Sales 1329.75 1343.94 -1.06 4996.47 5111.86 -2.26 5111.86 3925.18 30.23
Other Income -20.62 6.41 -421.68 9.12 15.08 -39.52 15.08 24.04 -37.27
PBIDT 121.02 134.54 -10.05 240.84 368.20 -34.59 368.21 204.24 80.28
Interest 75.15 47.89 56.92 213.93 206.10 3.80 206.11 230.75 -10.68
PBDT 39.93 850.33 -95.30 20.97 925.78 -97.73 925.78 -26.51 -3592.19
Depreciation 30.73 30.02 2.37 123.84 114.51 8.15 114.50 97.54 17.39
PBT 9.20 820.31 -98.88 -102.87 811.27 -112.68 811.28 -124.05 -753.99
TAX -0.95 -5.14 -81.52 1.10 -3.47 -131.70 -3.46 2.00 -273.00
Deferred Tax -0.95 -5.14 -81.52 1.10 -3.47 -131.70 -3.46 -20.68 -83.27
PAT 10.15 825.45 -98.77 -103.97 814.74 -112.76 814.74 -126.05 -746.36
Equity 327.06 326.66 0.12 327.06 326.66 0.12 326.66 250.15 30.59
PBIDTM(%) 9.10 10.01 -9.09 4.82 7.20 -33.08 7.20 5.20 38.43
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..